LSB

LakeShore Biopharma
LSB

Overview Fund Activity

11 hedge funds and large institutions have $4.89M invested in LakeShore Biopharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
2
Increased
–
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
1
Superstring Capital Management
New York
$166K
2
Citadel Advisors
2
Citadel Advisors
Florida
$23.1K

Top Sellers

1
O
1
OrbiMed
New York
$1.65M
2
SLM
2
Snow Lake Management
California
$0
3
Fidelity International
3
Fidelity International
Bermuda
$1.18M
4
CAC
4
Cowen and Company
New York
$0
5
Barclays
5
Barclays
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$1.65M 3,236,311 -1,305,111 -29%
Fidelity International
2
Fidelity International
Bermuda
$1.18M 2,202,328 -503,345 -19%
VAM
3
Valliance Asset Management
Hong Kong
$821K 1,607,175 – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$627K 1,165,071 – –
HA
5
HHLR Advisors
Cayman Islands
$404K 751,790 – –
SCM
6
Superstring Capital Management
New York
$166K 307,920 +307,920 New
Citadel Advisors
7
Citadel Advisors
Florida
$23.1K 42,855 +42,855 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$7.32K 13,608 – –
PAM
9
Pinpoint Asset Management
Hong Kong
$1.9K 50,000 – –
WAM
10
Wolverine Asset Management
Illinois
$254 499 – –
TRCT
11
Tower Research Capital (TRC)
New York
$2 4 -217 -98%
SLM
12
Snow Lake Management
California
– – -357,149 Closed
CAC
13
Cowen and Company
New York
– – -12,357 Closed
Barclays
14
Barclays
United Kingdom
– – -5,692 Closed
CFGS
15
Concourse Financial Group Securities
Alabama
– – – –